Form 8-K - Current report:
SEC Accession No. 0001104659-21-063497
Filing Date
2021-05-10
Accepted
2021-05-10 08:40:21
Documents
3
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115691d1_8k.htm 8-K 19868
2 EXHIBIT 99.1 tm2115691d1_ex99-1.htm EX-99.1 57015
3 GRAPHIC image_001.jpg GRAPHIC 3827
  Complete submission text file 0001104659-21-063497.txt   83589
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 21905387
SIC: 2834 Pharmaceutical Preparations